These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 22168435

  • 1. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK, McCarthy C, Kiernan G, McGorrian C, Keenan E, Mahon NG, Sweeney B.
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [Abstract] [Full Text] [Related]

  • 2. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
    Peles E, Bodner G, Kreek MJ, Rados V, Adelson M.
    Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M.
    Drug Alcohol Depend; 2009 Jan 01; 99(1-3):327-32. PubMed ID: 18774239
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H.
    Addiction; 2009 Jun 01; 104(6):993-9. PubMed ID: 19392907
    [Abstract] [Full Text] [Related]

  • 5. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.
    Drug Alcohol Rev; 2011 Jul 01; 30(4):388-96. PubMed ID: 21355918
    [Abstract] [Full Text] [Related]

  • 6. Onsite QTc interval screening for patients in methadone maintenance treatment.
    Fareed A, Vayalapalli S, Byrd-Sellers J, Casarella J, Drexler K, Amar R, Smith-Cox J, Lutchman TS.
    J Addict Dis; 2010 Jan 01; 29(1):15-22. PubMed ID: 20390695
    [Abstract] [Full Text] [Related]

  • 7. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O.
    Drug Alcohol Depend; 2013 Apr 01; 129(1-2):88-93. PubMed ID: 23084592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.
    Peles E, Linzy S, Kreek MJ, Adelson M.
    J Addict Med; 2013 Apr 01; 7(6):428-34. PubMed ID: 24145160
    [Abstract] [Full Text] [Related]

  • 12. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.
    Fanoe S, Hvidt C, Ege P, Jensen GB.
    Heart; 2007 Sep 01; 93(9):1051-5. PubMed ID: 17344330
    [Abstract] [Full Text] [Related]

  • 13. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization].
    Krook AL, Waal H, Hansteen V.
    Tidsskr Nor Laegeforen; 2004 Nov 18; 124(22):2940-1. PubMed ID: 15550974
    [Abstract] [Full Text] [Related]

  • 14. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A, Patil D, Scheinberg K, Blackinton Gale R, Vayalapalli S, Casarella J, Drexler K.
    J Addict Dis; 2013 Nov 18; 32(3):244-51. PubMed ID: 24074190
    [Abstract] [Full Text] [Related]

  • 15. QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.
    Fareed A, Vayalapalli S, Scheinberg K, Gale R, Casarella J, Drexler K.
    Am J Drug Alcohol Abuse; 2013 Jul 18; 39(4):235-40. PubMed ID: 23808912
    [Abstract] [Full Text] [Related]

  • 16. Impact of methadone treatment on cardiac repolarization and conduction in opioid users.
    Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN.
    Am J Cardiol; 2005 Apr 01; 95(7):915-8. PubMed ID: 15781034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A, Pathak A, Lapeyre-Mestre M.
    Fundam Clin Pharmacol; 2011 Aug 01; 25(4):503-10. PubMed ID: 20825488
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.